IRIDEX Corporation (NASDAQ:IRIX)
Q2 2014 Earnings Conference Call
July 31, 2014 05:00 p.m. ET
William M. Moore – Interim President and CEO
James H. Mackaness – Chief Financial Officer and Chief Operating Officer
IRIDEX Corporation (IRIX)
Q1 2014 Earnings Conference Call
May 1, 2014 17:00 ET
Will Moore - Chief Executive Officer
Jim Mackaness - Chief Financial Officer and Chief Operating Officer
Susan Bruce - Investor Relations
Q4 2013 Earnings Call
February 27, 2014 5:00 pm ET
William M. Moore - Chairman, Chief Executive Officer and President
James H. Mackaness - Chief Financial Officer, Chief Operating Officer and...
By Inflection Point Investing LLC:
Under-followed by the Street and unknown to most investors, ophthalmology pure-play, Iridex Corp. (IRIX), is both a compelling short-term and long-term investment opportunity. Buttressed by its sterling...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it has received the final $510,000 cash payment from the February 2012 sale of its aesthetic business unit. The cash was released to IRIDEX from an escrow account set up as part of the...
IRIDEX Corporation (NASDAQ: IRIX) today announced that it has entered into a global distribution and supply agreement with Peregrine Surgical, Ltd., a privately held company based in New Britain, Pennslvania. Under the agreement, IRIDEX will...
IRIDEX Corporation (NASDAQ: IRIX) announced today the final results of its tender offer to purchase up to 487,500 shares of its common stock at a purchase price of $4.10 per share, which expired at 5:00 p.m., New York City time, on Friday,...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to IRIDEX (IRIX):